Abstract
Immunity against the human malaria parasite Plasmodium falciparum was induced using somatic transgene immunization, a method to effectively target B lymphocytes in vivo. A single inoculation of plasmid DNA containing an immunoglobulin heavy-chain gene coding in the complementarity-determining region 3 for three repeats of the sequence Asn-Ala-Asn-Pro (NANP), a B-cell epitope of P. falciparum sporozoites, induced antibodies against NANP in all mice. A booster with an antibody antigenized with the NANP peptide, or challenge with P. falciparum sporozoites, demonstrated the establishment of immunologic memory. Immunity to a parasite antigen can be induced by exploiting mechanisms in which B lymphocytes are both the source of the immunogen as well as the effector mechanism of immunity. The results indicate that somatic transgene immunization is a potential approach for vaccination against foreign pathogens.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Salk, J. and Salk, D. 1977. Control of influenza and poliomyelitis with killed virus vaccines. Science 195: 834–847.
Zanetti, M., Sercarz, E., and Salk, J. 1987. The immunology of new generation vaccines. Immunol. Today 8: 18–25.
Cox, G., Zamb, T., and Babiuk, L. 1993. Bovine herpesvirus1: Immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67: 5664–5667.
Robinson, H., Hunt, L. and Webster, R. (1993). Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid. Vaccine 11: 957–960.
Wang, B., Ugen, K., Srikantan, V., Agadjanyan, M., Dang, Y., Refaeli, A. et al. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90: 4156–4160.
Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H. Felgner, R.L., Dwarki, V.J., et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749.
Sedegah, M., Hedstrom, R., Hobart, P., and Hoffman, S.L. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91: 9866–9870.
Raz, E., Carson, D.A., Parker, S.E., Parr, T.B., Abai, A.M., Aichinger, G., et al. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91: 9519–9523.
Davis, H.L., Michel, M.L., Mancini, M., Schleef, M., and Whalen, R.G. 1994. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12: 1503–1509.
Anderson, R., Gao, X.-M., Papakonstantinopoulou, A., Roberts, M., and Dougan, G. 1996. Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin. Infect. Imm. 64: 3168–3173.
Xiang, Z.Q., Spitalnik, S., Iran, M., Wunner, W.H., Cheng, J., and Ertl, H.C. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199: 132–140.
Davis, H.L., Whalen, R.G., and Demeneix, B.A. 1993. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4: 151–159.
Gerloni, M., Billetta, R., Xiong, S., and Zanetti, M. 1997. Somatic transgene immunization with DNA encoding an immunoglobulin heavy chain. DNA Cell Biol. 16: 611–625.
Gillies, S.D., Morrison, S.L., Oi, V.T., and Tonegawa, S. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33: 717–728.
Xiong, S., Gerloni, M., and Zanetti, M. 1997. in vivo role of B lymphocytes in somatic transgene immunization. Proc. Natl. Acad. Sci. USA 94: 6352–6357.
Zanetti, M. 1992. Antigenized antibodies. Nature 365: 466–477
Billetta, R., Hollingdale, R.M., and Zanetti, M. 1991. Immunogenicity of an engineered internal image antibody. Proc. Natl. Acad. Sci. USA 88: 4713–4717.
Lanza, P., Billetta, R., Antonenko, S., and Zanetti, M. 1993. Active immunity against the CD4 receptor using an antibody antigenized with residues 41–55 of the first extracellular domain. Proc. Natl. Acad. Sci. USA 90: 11683–11687.
Rigaudy, P., Simon, S., Hunter, T., Sollazzo, M., Billetta, R., Zanetti, M., and Eckhart, W. 1994. Antibodies specific for the neuronal form of the scr protein elicited by an antigenized antibody. DNA Cell Biol. 13: 585–591.
Zaghouani, H., Anderson, S.A., Sperber, K.E., Daian, C., Kennedy, R.C., Mayer, L., and Bona, C.A. 1995. Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc. Natl. Acad. Sci. USA 92: 631–635.
Sollazzo, M., Billetta, R., and Zanetti, M. Expression of an exogenous peptide epitope genetically engineereed in the variable domain of an immunoglobulin: implications for antibody and peptide folding. Prot. Eng. 4: 215–220. 1990.
Zaghouani, H., Steinman, R., Nonacs, R., Shah, H., Gerhard, W., and Bona, C. 1993. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 259: 224–227.
Zavala, F., Tam, J.P., Hollingdale, M.R., Cochrane, A.H., Quakyi, I., Nussenzweig, R.S., and Nussenzweig, V. 1985. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228: 1436–1440.
Nardin, E.H., Nussenzweig, R.S., McGregor, I.A., and Bryan, J.H. 1979. Antibodies to sporozoites: Their frequent occurrence in individuals living in an area of hyperendemic malaria. Science 206: 597–601.
Clyde, D.F., McCarthy, V.C., Miller, R.M., and Hornick, R.B. 1973. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266: 398–403.
Calle, J.M., Nardin, E.H., Clavijo, P., Boudin, C., Stuber, D., Takacs, B., et al. 1992. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers. J. Immunol. 149: 2695–2701.
Egan, J.E., Hoffman, S.L., Haynes, J.D., Sadoff, J.C., Schneider, I., Grau, G.E., et al. 1993. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trop. Med. Hyg. 49: 166–173.
Ballou, W.R., Hoffman, S.L., Sherwood, J.A., Hollingdale, M.R., Neva, F.A., Hockmeyer, W.T., et al. 1987. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1: 1277–1281.
Herrington, D.A., Clyde, D.F., Losonsky, G., Cortesia, M., Murphy, J.R., Davis, J. et al. 1987. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature 328: 257–259.
Edelman, R., Hoffman, S.L., Davis, J.R., Beier, M., Sztein, M.B., Losonsky, G. et al. 1963. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. J. Infect Dis 168: 1066–1070.
Dresser, D.W. and Mitchison, N.A. 1968. The mechanism of immunological paralysis. Adv. Immunol. 8: 129–181.
Stoute, J.A., Slaoui, M., Heppner, D.G., Momin, P., Kester, K.E., Desmons, P., et al. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS.S Malaria Vaccine Evaluation Group [see comments]. New Engl. J. Med. 336: 86–91.
Munesinghe, D.Y., Clavijo, P., Calle, M.C., Nussenzweig, R.S., and Nardin, E. 1991. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein. Eur. J. Immunol. 21: 3015–3020.
Xiong, S., Gerloni, M., and Zanetti, M. 1997. Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes. Nature Biotechnology 15: 882–886.
Gerloni, M., Lo, D., and Zanetti, M. 1997. DNA immunization in relB-deficient mice discloses a role for dendritic cells in IgG1-IgM switch in vivo. Eur. J. Immunol. Eur. J. Immunol. In press.
Kemp, D.J., Coppel, R.L., and Anders, R.F. 1987. Repetitive proteins and genes of malaria. Annu. Rev. Microbiol. 41: 181–208.
Hoffman, S.L., Nussenzweig, V., Sadoff, J.C., and Nussenzweig, R.S. 1991. Progress toward malaria vaccine preerythrocytic vaccines. Science 252: 520–521.
Etlinger, H.M. and Trzeciak, A. 1993. Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 340: 69–72.
Green, T.J. and Packer, B.J. 1984. A role for rheumatoid factor enhancement of Plasmodium falciparum schizont inhibition in vitro. Infect. Immun. 46: 668–672.
Wirtz, R.A., Ballou, W.R., Schneider, I., Chedid, L., Gross, M.J., Young, J.F. et al. 1987. Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli. Exp. Parasitol. 63: 166–172.
Billetta, R. and Zanetti, M. 1992. Ligand expression using antigenization of antibody: Principle and methods. ImmunoMeihods 1: 41–51.
Sollazzo, M., Hasemann, C.A., Meek, K.D., Glotz, D., Capra, J.D., and Zanetti, M. 1989. Molecular characterization of the VH region of murine autoan-tibodies from neonatal and adult BALB/c mice. Eur. J. Immunol. 19: 453–457.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gerloni, M., Ballou, W., Billetta, R. et al. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization. Nat Biotechnol 15, 876–881 (1997). https://doi.org/10.1038/nbt0997-876
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0997-876
This article is cited by
-
Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells
Nature Biotechnology (1999)
-
Elegantly presented DNA vaccines
Nature Biotechnology (1997)
-
Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes
Nature Biotechnology (1997)